University of Colorado School of Dental Medicine
Aurora, Colorado, 80045, United States
Location status: Recruiting
NCT Number: NCT03906422
Three different types of 'archwires' can be used in Orthodontic treatment, wire choice is decided by treating Orthodontist based on professional preference since research shows that all types are equally effective.
It is possible that one type of wire engenders more patient discomfort. This study will compare the discomfort levels engendered by the three wire types to determine if there is one that induces the least amount.
Interested in participating?
Request Info12 year and older
All sexes
Interventional
Not applicable
Aurora, Colorado, 80045, United States
Location status: Recruiting
Orthodontic treatment with fixed appliances has the potential to induce pain in patients. At the beginning of treatment, the orthodontist must determine which initial orthodontic archwire to insert. Among the more popular choices for initial leveling and aligning of the dental arches are small-sized, round-diameter nickel-titanium archwires. Various types of nickel-titanium (NiTi) archwires exist including stabilized martensitic wires (ie classic Nitinol), active austenitic wires (superelastic NiTi) and active martensitic wires (thermoelastic NiTi). The efficacy of these wire types has been heavily researched with no significant differences in the alignment timing of the dentition (treatment time to reach the final archwire). Pain differences from these wires has been inconclusive from conflicting past studies. It is of critical importance to determine whether one or more of these archwires leads to more discomfort for the patient than the others.
Healthy volunteers accepted: Yes
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
Placement of 3M Unitek 0.016 archwire for orthodontic treatment
Placement of 0.016" Ormco 27oC NiTi orthodontic archwire
Placement of 0.016" Ormco 35oC NiTi orthodontic archwire
Time frame: 1 hour, 4 hour, 24 hour, 4 day and 7 day
The primary outcome is the change in pain experienced by the study participant over the first week of therapy after insertion of the archwire.
Pain is assessed by asking the study participant to place a mark on a horizontal 100 mm line to indicate the level of pain being experienced. The left end of the line is no pain where the right end is maximum (unimaginable) pain. The specific pain indicated is in the number of millimeters from the left end of the line. This is called the Visual Analogue Score (VAS) where the higher the number the more intense the pain.
The difference in VAS pain scores from the initial VAS after archwire insertion (1 hour) to each measurement time (4 hour, 24 hour, 4 day and 7 day) over 7 days will indicate the change pain experience for each study participant.
For each time point the mean and standard deviation of the change in VAS pain scores for the experimental groups will be calculated and compared for statistically significant differences.
Contact information is provided by the study sponsor or research team.
Clifton M Carey, PhD
CONTACT
Craig Shellhart, DDS
CONTACT
University of Colorado, Denver
Other
Comparison of Patient-reported Pain After Initial Archwire Placement With Three Types of Nickel-titanium Archwires: a Prospective Triple-blind, Randomized Controlled Clinical Trial
Acronym: Archwires
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT07687810
Non-Pharmacological Pain Management, Orthodontic Discomfort
Ajman, Ajman Emirate, United Arab Emirates
View Trial DetailsNCT04059172
Facial Pain, Neurologic Manifestations
Aurora, Colorado, United States
View Trial DetailsNCT07321483
Craniomandibular Disorders, Facial Pain
Olomouc, Czechia
View Trial DetailsNCT04948541
Apnea, Craniomandibular Disorders
Roma, RM, Italy
View Trial Details